PMC:7170399 / 9168-10045 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"112","span":{"begin":303,"end":315},"obj":"Chemical"},{"id":"113","span":{"begin":372,"end":375},"obj":"Disease"}],"attributes":[{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"MESH:D000386"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012–2018) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). In the past 5 years she has prepared a report under contract for Shire Pharmaceuticals) and received honoraria for education of psychiatrists from Shire Pharmaceuticals (Takeda group). All views in this paper are her own."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T51","span":{"begin":12,"end":15},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T52","span":{"begin":324,"end":327},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T53","span":{"begin":499,"end":501},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T54","span":{"begin":543,"end":547},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"},{"id":"T55","span":{"begin":680,"end":683},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T56","span":{"begin":693,"end":694},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012–2018) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). In the past 5 years she has prepared a report under contract for Shire Pharmaceuticals) and received honoraria for education of psychiatrists from Shire Pharmaceuticals (Takeda group). All views in this paper are her own."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":833,"end":838},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012–2018) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). In the past 5 years she has prepared a report under contract for Shire Pharmaceuticals) and received honoraria for education of psychiatrists from Shire Pharmaceuticals (Takeda group). All views in this paper are her own."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T21","span":{"begin":406,"end":412},"obj":"http://purl.obolibrary.org/obo/GO_0007631"},{"id":"T22","span":{"begin":520,"end":526},"obj":"http://purl.obolibrary.org/obo/GO_0007631"},{"id":"T23","span":{"begin":615,"end":621},"obj":"http://purl.obolibrary.org/obo/GO_0007631"}],"text":"PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012–2018) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). In the past 5 years she has prepared a report under contract for Shire Pharmaceuticals) and received honoraria for education of psychiatrists from Shire Pharmaceuticals (Takeda group). All views in this paper are her own."}

{"project":"LitCovid-sentences","denotations":[{"id":"T84","span":{"begin":0,"end":376},"obj":"Sentence"},{"id":"T85","span":{"begin":377,"end":655},"obj":"Sentence"},{"id":"T86","span":{"begin":656,"end":840},"obj":"Sentence"},{"id":"T87","span":{"begin":841,"end":877},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012–2018) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). In the past 5 years she has prepared a report under contract for Shire Pharmaceuticals) and received honoraria for education of psychiatrists from Shire Pharmaceuticals (Takeda group). All views in this paper are her own."}